Compare DLR & IDXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLR | IDXX |
|---|---|---|
| Founded | 2004 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.3B | 57.1B |
| IPO Year | N/A | 1996 |
| Metric | DLR | IDXX |
|---|---|---|
| Price | $176.00 | $635.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 9 |
| Target Price | $192.88 | ★ $715.00 |
| AVG Volume (30 Days) | ★ 1.9M | 474.4K |
| Earning Date | 01-01-0001 | 05-04-2026 |
| Dividend Yield | ★ 2.76% | N/A |
| EPS Growth | N/A | ★ 6.06 |
| EPS | N/A | ★ 9.99 |
| Revenue | N/A | ★ $3,897,504,000.00 |
| Revenue This Year | $10.84 | $10.81 |
| Revenue Next Year | $11.22 | $8.62 |
| P/E Ratio | ★ $49.16 | $63.06 |
| Revenue Growth | N/A | ★ 6.46 |
| 52 Week Low | $129.95 | $356.25 |
| 52 Week High | $184.79 | $769.98 |
| Indicator | DLR | IDXX |
|---|---|---|
| Relative Strength Index (RSI) | 64.11 | 40.13 |
| Support Level | $175.22 | $606.04 |
| Resistance Level | $182.55 | $639.29 |
| Average True Range (ATR) | 4.26 | 18.33 |
| MACD | 0.47 | -0.25 |
| Stochastic Oscillator | 62.13 | 56.18 |
Digital Realty owns and operates over 300 data centers worldwide. It has nearly 40 million rentable square feet across five continents. Digital's offerings range from retail co-location, where an enterprise may rent a single cabinet and rely on Digital to provide all the accommodations, to "cold shells," where hyperscale cloud service providers can simply rent much, or all, of a barren, power-connected building. In recent years, Digital Realty has deemphasized cold shells and now primarily provides higher-level service to tenants that outsource their related IT needs to Digital. The company operates as a real estate investment trust.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.